» Articles » PMID: 35216873

The Adjunct of Electric Neurostimulation to Rehabilitation Approaches in Upper Limb Stroke Rehabilitation: A Systematic Review With Network Meta-Analysis of Randomized Controlled Trials

Overview
Journal Neuromodulation
Publisher Elsevier
Date 2022 Feb 26
PMID 35216873
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This review analyzed the current evidence and the potential for the application of electric neurostimulation such as transcranial direct current stimulation (tDCS) and vagus nerve stimulation (VNS) in upper limb stroke rehabilitation.

Materials And Methods: We performed a systematic review of randomized controlled trials (RCTs) using network meta-analysis (NMA), searching the following data bases: PubMed, Web of Science, Cochrane, and Google Scholar, using specific keywords, from January 2010 to April 2021, and assessing the effects of "tDCS" or "VNS" combined with other therapies on upper limb motor function and activities of daily living (ADL) after stroke.

Results: We included 38 RCTs with 1261 participants. Pairwise NMA showed transcutaneous VNS (tVNS) and anodal tDCS were effective in improving upper limb motor function (tVNS: mean difference [MD]: 5.50; 95% CI [0.67-11.67]; p < 0.05; anodal tDCS: MD: 5.23; 95% CI [2.45-8.01]; p < 0.05). tVNS and tDCS (anodal and cathodal) were also effective in improving ADL performance after stroke (tVNS: standard MD [SMD]: 0.96; 95% CI [0.15-2.06]; p < 0.05; anodal tDCS: SMD: 3.78; 95% CI [0.0-7.56]; p < 0.05; cathodal tDCS: SMD: 5.38; 95% CI [0.22-10.54]; p < 0.05). Surface under the cumulative ranking curve analysis revealed that tVNS is the best ranked treatment in improving upper limb motor function and performance in ADL after stroke. There was no difference in safety between VNS and its control interventions, measured by reported adverse events (VNS: risk ratio = 1.02 [95% CI = 0.48-2.17; I = 0; p = 0.96]).

Conclusion: Moderate- to high-quality evidence suggests that tVNS and anodal tDCS were effective in improving upper limb motor function in both acute/subacute and chronic stroke. In addition to tVNS and anodal tDCS, cathodal tDCS is also effective in improving ADL performance after stroke.

Citing Articles

Comparative efficacy and acceptability of non-invasive neuromodulation technologies and botulinum toxin injections for post-stroke spasticity and motor function: a network meta-analysis of randomised controlled trials.

Huang J, Bao C, Chen Y, Zhu W, Zhang K, Liu C EClinicalMedicine. 2025; 80():103034.

PMID: 39831129 PMC: 11741030. DOI: 10.1016/j.eclinm.2024.103034.


The effectiveness of home-based transcranial direct current stimulation on chronic pain: A systematic review and meta-analysis.

Antonioni A, Baroni A, Fregna G, Ahmed I, Straudi S Digit Health. 2024; 10:20552076241292677.

PMID: 39600390 PMC: 11590159. DOI: 10.1177/20552076241292677.


Clinical Comparison between HD-tDCS and tDCS for Improving Upper Limb Motor Function: A Randomized, Double-Blinded, Sham-Controlled Trial.

Zeng Y, Cheng R, Zhang L, Fang S, Zhang S, Wang M Neural Plast. 2024; 2024:2512796.

PMID: 38585306 PMC: 10999289. DOI: 10.1155/2024/2512796.


Update on Non-invasive Brain Stimulation on Stroke Motor Impairment: A Narrative Review.

Kim S, Park H Brain Neurorehabil. 2024; 17(1):e5.

PMID: 38585032 PMC: 10990843. DOI: 10.12786/bn.2024.17.e5.


Priming transcranial direct current stimulation for improving hemiparetic upper limb in patients with subacute stroke: study protocol for a randomised controlled trial.

Zhu F, Xu X, Jin M, Chen J, Feng X, Wang J BMJ Open. 2024; 14(2):e079372.

PMID: 38309762 PMC: 10840068. DOI: 10.1136/bmjopen-2023-079372.